Equities

UDG Healthcare PLC

UDG Healthcare PLC

Actions
Health CareHealth Care Equipment & Services
  • Price (GBX)919.50
  • Today's Change9.50 / 1.04%
  • Shares traded169.13k
  • 1 Year change40.49%
  • Beta0.7575
Data delayed at least 20 minutes, as of Oct 20 2017 15:17 BST.
More ▼

Key statistics

UDG Healthcare PLC (UDG:LSE) set a new 52-week high during today's trading session when it reached 922.50. Over this period, the share price is up 38.79%.
52-week range
Today
612.00Nov 25 2016922.50Oct 20 2017
Markit short selling activity
Low
Med
High
Open912.00
High922.50
Low912.00
Bid919.50
Offer920.00
Previous close910.00
Average volume373.55k
Shares outstanding248.33m
Free float245.58m
P/E (TTM)41.08
Market cap2.27bn GBP
EPS (TTM)0.2223
GBP
Annual div (ADY)10.18
GBX
Annual div yield (ADY)1.12%
Div ex-dateJun 01 2017
Div pay-dateJun 27 2017
Data delayed at least 20 minutes, as of Oct 20 2017 15:17 BST.
More ▼

Investors Chronicle View

The last IC recommendation on UDG Healthcare PLC shares was Buy at 853.00 on 18 Sep 2017Read the full article

Board of Directors

1/11

Peter Gray, Chairman

2/11

Brendan McAtamney, Chief Operating Officer

3/11

Alan Ralph, Chief Financial Officer

4/11

Chris Corbin, Chairman of Ashfield Commercial and Medical Services

5/11

Chris Brinsmead, Non-Executive Director

6/11

Gerard van Odijk, Non-Executive Director

7/11

Lisa Ricciardi, Non-Executive Director

8/11

Linda Wilding, Non-Executive Director

9/11

Philip Toomey, Non-Executive Director

10/11

Nancy Miller-Rich, Non-Executive Director

11/11

Myles Lee, Non-Executive Director

Investor Relations Contact

Alan Ralph

CFO

UDG Healthcare plc

20 Riverwalk

Citywest Business Campus

Dublin 24

Ireland

Keith Byrne

Head of Investor Relations & Strategy

UDG Healthcare plc

20 Riverwalk

Citywest Business Campus

Dublin 24

Ireland


Tel: + 353 1 468 9000

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.